Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
CELU
HOWL
Add up to 3 more stocks
CELU
Celularity Inc.
-7.60%
$1.58-0.13Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$45.73M
52W Range
$0.56 - $2.55
HOWL
Werewolf Therapeutics, Inc.
-1.05%
$0.92-0.01Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$44.72M
52W Range
$0.27 - $2.15
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | N/A | 2.74 |
| P/S Ratio | 2.41 | 2.13 |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 79.6% | 0.0% |
| Operating Margin | -230.9% | 0.0% |
| Net Margin | -375.8% | -164.8% |
| ROE | N/A | -212.4% |
| ROA | -71.7% | -143.3% |
| ROIC | -193.0% | -157.0% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 0.09 | 2.91 |
| Quick Ratio | 0.08 | 2.91 |
| Debt/Equity | N/A | 0.00 |
| Interest Coverage | -9.08 | -11.50 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.